Program Information
Absolute Film Dosimetry for Stereotactic Radiosurgery and Stereotactic Body Radiotherapy Quality Assurance Using Gafchromic EBT3 Films
N Wen*, S Lu , Y Qin , Y Huang , B Zhao , C Liu , I Chetty , Henry Ford Health System, Detroit, MI
Presentations
SU-F-T-566 (Sunday, July 31, 2016) 3:00 PM - 6:00 PM Room: Exhibit Hall
Purpose:To evaluate the dosimetric uncertainty associated with Gafchromic (EBT3) films and establish an absolute dosimetry protocol for Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT).
Methods: EBT3 films were irradiated at each of seven different dose levels between 1 and 15 Gy with open fields, and standard deviations of dose maps were calculated at each color channel for evaluation. A scanner non-uniform response correction map was built by registering and comparing film doses to the reference diode array-based dose map delivered with the same doses. To determine the temporal dependence of EBT3 films, the average correction factors of different dose levels as a function of time were evaluated up to four days after irradiation. An integrated film dosimetry protocol was developed for dose calibration, calibration curve fitting, dose mapping, and profile/gamma analysis. Patient specific quality assurance (PSQA) was performed for 93 SRS/SBRT treatment plans.
Results: The scanner response varied within 1% for the field sizes less than 5 x 5 cm², and up to 5% for the field sizes of 10 x 10 cm². The scanner correction method was able to remove visually evident, irregular detector responses found for larger field sizes. The dose response of the film changed rapidly (~10%) in the first two hours and plateaued afterwards, ~3% change between 2 and 24 hours. The mean uncertainties (mean of the standard deviations) were <0.5% over the dose range 1~15Gy for all color channels for the OD response curves. The percentage of points passing the 3%/1mm gamma criteria based on absolute dose analysis, averaged over all tests, was 95.0 ± 4.2.
Conclusion:We have developed an absolute film dose dosimetry protocol using EBT3 films. The overall uncertainty has been established to be approximately 1% for SRS and SBRT PSQA.
Funding Support, Disclosures, and Conflict of Interest: The work was supported by a Research Scholar Grant, RSG-15-137-01-CCE from the American Cancer Society
Contact Email: